ConductScience.org, home

Paper109196

Variable oral absorption of hexamethylmelamine in man.

D'Incalci M and 4 others. Cancer Treat Rep, 1978. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. Variable oral absorption of hexamethylmelamine in man. Papers, record 109196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/109196

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Variable oral absorption of hexamethylmelamine in man.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
3.49
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1D'Incalci MM
2Bolis GG
3Mangioni CC
4Morasca LL
5Garattini SS

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AltretamineMajor topic
TriazinesMajor topic
Absorption
Administration, Oral
Adult
Aged
Female
Half-Life
Humans
Middle Aged
Ovarian Neoplasms

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
9387041Preclinical pharmacokinetic, antitumor and toxicity studies with CI-994 (correction of CL-994) (N-acetyldinaline).Invest New Drugs1997https://conductscience.org/library/papers/9387041PubMed
8174199Is body composition an important variable in the pharmacokinetics of anticancer drugs? A review and suggestions for further research.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8174199PubMed
7656502Clinical pharmacokinetics of altretamine.Clin Pharmacokinet1995https://conductscience.org/library/papers/7656502PubMed
7641606Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.Drugs1995https://conductscience.org/library/papers/7641606PubMed
6994913The practical benefits of pharmacokinetics in the use of antineoplastic agents.Cancer Chemother Pharmacol1980https://conductscience.org/library/papers/6994913PubMed
6808457Hexamethylmelamine and hexamethylmelamine hydrochloride.Pharm Weekbl Sci1982https://conductscience.org/library/papers/6808457PubMed
6770884Time dependence of the in vitro cytotoxicity of hexamethylmelamine and its metabolites.Br J Cancer1980https://conductscience.org/library/papers/6770884PubMed
6432969Human central nervous system pharmacology of pentamethylmelamine and its metabolites.J Neurooncol1983https://conductscience.org/library/papers/6432969PubMed
6411375Distribution, metabolism, and irreversible binding of hexamethylmelamine in mice bearing ovarian carcinoma.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6411375PubMed
6409137Clinical correlates of in vitro drug sensitivities of ovarian cancer cells.Br J Cancer1983https://conductscience.org/library/papers/6409137PubMed
6401427Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studies.Br J Cancer1983https://conductscience.org/library/papers/6401427PubMed
3888428Anticancer drug pharmacodynamics.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3888428PubMed
3552281N-methyl antitumour agents. A distinct class of anticancer drugs?Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3552281PubMed
3315280Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3315280PubMed
3311530Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.Clin Pharmacokinet1987https://conductscience.org/library/papers/3311530PubMed
3117395Metabolism of hexamethylmelamine in mice.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3117395PubMed
3098444Superior efficacy of trimelamol to hexamethylmelamine in human ovarian cancer xenografts.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3098444PubMed
2515524The bioavailability of three altretamine formulations.Pharm Weekbl Sci1989https://conductscience.org/library/papers/2515524PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/109196

GET https://conductscience.org/api/papers/v1/109196/authors